Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo
Official title: A Randomized, Double-blind, Placebo-controlled Phase Ib/II Clinical Trial of Multiple Subcutaneous Injections of GR2301 in Combination With Phototherapy to Evaluate the Tolerability, Safety, Pharmacokinetics, and Preliminary Efficacy in Trial Participants With Vitiligo
Status: Opening soon
Description:
This is a randomized, double-blind, placebo-controlled Phase Ib/II clinical trial of multiple subcutaneous injections of GR2301 in combination with phototherapy to evaluate the tolerability, safety, pharmacokinetics, and preliminary efficacy in trial participants with vitiligo. The trial will be conducted in two stages: a dose-escalation stage (Phase Ib) and an expansion cohort stage (Phase II).
Phases: Phase 1, Phase 2.
What is being studied: biologicals — GR2301 injection, Placebo.
Who can take part: ages 18 Years to 65 Years, 116 participants planned.
Enrollment status: Opening soon. The study started 01 June 2026 and is expected to finish 01 December 2028.
Contact: liaison officer.
Source: ClinicalTrials.gov, NCT07647237 (https://clinicaltrials.gov/study/NCT07647237).
Start date: June 01, 2026
Completion date: December 01, 2028
Organizer: Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Contact: liaison officer
Tel.: 021-50805988-8039
Email: shuxueye@genrixbio.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a generally unpredictable skin disease that causes a gradual loss of skin color and overlying hair on different parts of the body. Contr...
- Why Does the IRS Still Show an Old Revocation for VR Foundation?
IRS Status · A Short FAQ The old entry records the past. Publication 78 shows where VR Foundation stands today. Updated August 2026 · EIN 45-2498489 Tax records are rarely elega...
- Pyrostegia venusta as a folk medicine for vitiligo?
Pyrostegia venusta, also known as “flame vine” or “cipó-de-são-joão,” is a neotropical evergreen vine native to Brazil. It thrives in fields, coastal areas, forest edges, and ro...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.